Clinical Trials
All Clinical Trials - Page 25 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT04532801Phase 1Withdrawn
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance
Kisspeptin
- NCT04064840Phase 3Recruiting
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
Gonadorelin
- NCT05162183N/ACompleted
Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Liraglutide
- NCT03648554Phase 4Unknown
Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
Dulaglutide
- NCT04039503Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Tirzepatide
- NCT04004988Phase 1Completed
A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
Tirzepatide
- NCT03963752Phase 4Completed
Clinical Trial of Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western Medicine
Gonadorelin
- NCT04067999N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
Semaglutide
- NCT04037488N/AUnknown
Changes in Body Composition With Patients Under Androgen Deprivation Therapy
Gonadorelin
- NCT03987919Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
Tirzepatide
- NCT03940742Phase 1Completed
A Study of Tirzepatide in Participants With Impaired Liver Function
Tirzepatide
- NCT04029272Phase 4Unknown
Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
Exenatide
- NCT04012255Phase 1Terminated
A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
Semaglutide
- NCT03970044Phase 4Completed
Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Exenatide
- NCT03996434Phase 4Completed
Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS
Gonadorelin
- NCT03996993N/AUnknown
Defining Recurrent Disease With Axumin™
Gonadorelin
- NCT01311518Phase 2Withdrawn
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
TB-500
- NCT03951753Phase 1Completed
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)
Tirzepatide
- NCT04007107Phase 2Completed
A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
Semaglutide
- NCT03948347N/AUnknown
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT03421119Phase 3Unknown
Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
Liraglutide
- NCT03989232Phase 3Completed
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Semaglutide
- NCT03987451Phase 2Completed
A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
Semaglutide
- NCT03914326Phase 3Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Semaglutide
- NCT03819153Phase 3Completed
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
Semaglutide
- NCT03973047Phase 1Completed
Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
PT-141
- NCT03929744Phase 1Completed
A Study of LY3502970 in Healthy Participants
Orforglipron
- NCT03822468Phase 2Completed
Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
Gonadorelin
- NCT03954834Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
Tirzepatide
- NCT03962010Phase 2Unknown
A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
Dulaglutide
- NCT03942653Phase 2Recruiting
Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma
Gonadorelin
- NCT03929679N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
Semaglutide
- NCT03937882Phase 3Completed
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
TB-500
- NCT03923114N/ACompleted
Imaging Pituitary ActiVation by Exendin
Exenatide
- NCT05029076Phase 1Completed
Human Bioequivalence Test of Liraglutide Injection
Liraglutide
- NCT04019197Phase 2Active Not Recruiting
Effects of Semaglutide in HIV-Associated Lipohypertrophy
Semaglutide
- NCT03951831Phase 2Active Not Recruiting
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
Gonadorelin
- NCT03961256Phase 2Completed
Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
Exenatide
- NCT03811561Phase 3Active Not Recruiting
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
Semaglutide
- NCT03931915Phase 3Completed
Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis
Gonadorelin
- NCT03861052Phase 3Completed
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
Tirzepatide
- NCT04185350EARLY_Phase 1Unknown
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
Exenatide
- NCT03919929Phase 2/Phase 3Completed
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
Semaglutide
- NCT04648969Phase 2Completed
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
Kisspeptin
- NCT03645408Phase 1Terminated
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
Exenatide
- NCT03899402Phase 2/Phase 3Active Not Recruiting
Triple Therapy in T1DM
Semaglutide
- NCT03876015N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)
Semaglutide
- NCT03940495N/ACompleted
Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?
Kisspeptin
- NCT04034524N/AUnknown
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
Liraglutide
- NCT03985384Phase 4Completed
Semaglutide Treatment On Coronary Progression
Semaglutide